Managers / Q2 2024 · view latest →
Bear Mountain Capital, Inc.
CIK 0002009419 · 2001 6TH AVENUE, STE 2401, SEATTLE, WA, 98121 · 206-420-3713
Summary
Bear Mountain Capital, Inc. reported $246M in U.S.-listed holdings across 182 positions for Q2 2024.
Its largest position, Vanguard Mid Cap, represents 14.6% of the portfolio.
Compared with Q1 2024, the fund opened 3 new positions and exited 45.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- ETP · 96.7% · $238M
- Common Stock · 3.2% · $8M
- REIT · 0.1% · $245,437
- MLP · 0.0% · $58,724
- ADR · 0.0% · $51,000
- Other · 0.0% · $7,940
Quarter-over-Quarter Changes full breakdown →
vs Q1 2024 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| TAT&T INC COM | NEW | +50 | 50 | +$941 | $941 |
| KLGWK KELLOGG CO COM SHS | NEW | +50 | 50 | +$788 | $788 |
| PFEPFIZER INC COM | NEW | +20 | 20 | +$578 | $578 |
| CMGCHIPOTLE MEXICAN GRILL INC COM | ADDED | +98 | 100 | −$39 | $5,767 |
| NVDANVIDIA CORPORATION COM | ADDED | +9.5K | 10.7K | +$366,542 | $1M |
| PHATPHATHOM PHARMACEUTICALS INC COM | ADDED | +800 | 1.0K | +$9,690 | $11,650 |
| VANGUARD S&P 500 GROWTH ETF | ADDED | +32 | 62 | +$12,590 | $21,424 |
| CRWDCROWDSTRIKE HLDGS INC CL A | SOLD OUT | −107 | 0 | −$31,425 | $0 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q2 2024
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $333M | 198 | May 12, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $310M | 199 | Jan 22, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $299M | 323 | Nov 12, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $279M | 182 | Jul 23, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $259M | 344 | May 2, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $257M | 176 | Feb 3, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $253M | 175 | Oct 29, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $246M | 182 | Jul 23, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $232M | 224 | Apr 25, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $238M | 235 | Jan 30, 2024 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.